S100A16 and breast carcinoma: As such, our study provides compelling evidence underscoring the key role the nucleolus plays in metastasis; more specifically, nucleolar S100A16 promotes metastasis by enhancing ribosome biogenesis-driven EMT, representing a potential therapeutic target in metastatic breast cancer.